Simon J. Cook. "Second MEK Inhibitor Shows Promise in Neurofibromatosis Type 1 With Symptomatic Plexiform Neurofibromas Signaling Hope for Other RASopathies." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco-24-02375